home > resource center > insights


  • Regulation’s impact on managing collateral relationships now and in the future
    • Insight providers: David White, Product Marketing Executive & Susan Hinko, Head of Industrial Relations, TriOptima Clear Path Analysis has put together a report that explores the evolving role of securities lending in a cleared environment, operational infrastructure changes and the practical challenges institutional investors must consider for optimum deriva
  • La reconciliación de carteras de Derivados OTC facilita el informe de las operaciones y el acuerdo de los UTI
    • Insight provider: Mara Moreno Todos los participantes en el mercado de derivados OTC y sujetos a EMIR tendrán que cumplir con la fecha límite del informe de sus operaciones estipulado por la European Securities y Markets Authority (ESMA) en febrero del próximo año. Podemos decir que los participantes del mercado se han compromet
  • Umsetzung der ESMA-Richtlinien zur Portfolioabstimmung und Streitbeilegung
    • Der CEO des triResolve Service von TriOptima, Raf Pritchard, erläutert die wesentliche Funktion von verlässlichen und automatisierten Systemen im Zusammenhang mit der Abstimmung von OTC-Derivateportfolios und der Untersuchung von Streitigkeiten, um den Auflagen der am 15. September 2013 in Kraft tretenden neuen ESMA-Regeln zu entsprechen. F: Wie lauten
  • Preparing for Portfolio Reconciliation and Dispute Resolution Requirements under ESMA
    • Insight provider: Raf Pritchard, CEO triResolve Raf Pritchard, CEO of TriOptima’s triResolve service, talks about the importance of implementing robust, automated systems for OTC derivative portfolio reconciliation and dispute investigation to prepare for the new ESMA rules that are effective September 15, 2013. Q: What are the new regulations regarding
  • DerivSource webinar recording
    • 2013 EMIR reconciliation, resolution and disclosure protocol to comply with EMIR’s September 15th requirements EMIR compliance for bilateral risk mitigation techniques for non-centrally cleared derivatives is required from September 15th. The ISDA 2013 EMIR Reconciliation, Resolution and Disclosure Protocol is designed to facilitate compliance wi
  • Reconciliation: Key to controlling OTC derivative exposures for the buy side
    • Insight providers: Mary Harris, Business Manager triResolve and Susan Hinko, Head of Industry Relations, TriOptima The new year brings with it an onslaught of requirements for managing OTC derivative portfolios, cleared and uncleared alike; and also presents new challenges with parallel tracks for processing and collateralizing the transactions. While standard
  • Clearing Risk
    • [Video] Insight provider: Mireille Dyrberg, COO, TriOptima The push to clear more trades means participants' fortunes are tied to the security and reliability of their counterparties. Mireille Dyrberg, chief operating officer with post-trade service company TriOptima, explains to FT Trading Room editor Philip Stafford how 'tearing up' of long-dated co
  • How to Adjust Processes to Comply with New Financial Regulation
    • Insight provider: David White, triResolve Product Marketing Executive, TriOptima In a Q&A, TriOptima’s David White explores the impact new financial regulation will have on portfolio reconciliation and dispute resolution processing and how firms can adjust operations to comply with new rules. Q. What is the current portfolio reconciliation
  • The changing regulatory environment
    • [video] Insight provider: Per Sjöberg, Group CEO, TriOptima The ongoing regulatory overhaul is forcing more firms to find ways to reduce risk and improve capital efficiencies. TriOptima has been working with firms on both issues using its triResolve service for portfolio reconciliation and triReduce services, for portfolio compression. The firm’s se
  • Exposure management in a cleared world
    • [video] Insight provider: Raf Pritchard, CEO triResolve, TriOptima Raf Pritchard, CEO of triResolve, speaks to Tabb’s Kevin McPartland about how TriOptima is tailoring its services in response to changes within the OTC derivatives world as new regulations are implemented and clearing gains traction. Whether it’s offering triReduce compression
  • It’s transparency, but not as we know it
    • Insight providers: Per Sjöberg, Executive Vice President, and Susan Hinko, Global Head of Industry Relations, TriOptima There is a widely-held belief that the over-the-counter (OTC) derivatives market and the pricing of transactions are too opaque and not accessible to the general public. Real time reporting and price transparency are viewed as th
  • TriOptima supports the ISDA Asia Pacific reconciliation pilot
    • Insight provider: Susan Hinko, Global Head of Industry Relations. The continuing ISDA-sponsored pilot of proactive portfolio reconciliation for OTC derivatives in the Asia Pacific region is further evidence of the globalization of regulatory standards. Large international banks are already required by American and European regulators to reconcile their OTC de
  • Structuring a trade repository to achieve regulatory goals
    • Insight provider: Per Sjöberg, Executive Vice President, TriOptima. TriOptima was selected by the industry to provide the Global Interest Rate Trade Reporting Repository (Rates Repository). The Rates Repository went live in January 2010 and public reporting began in March 2010. Based on TriOptima’s experiences with the Rates Repository, Mr. Sjöber
Please enter your full name.

Interest Rate Trade Reporting Repository
Terms and Conditions for Access and Use

1. Scope of Agreement
    These terms and conditions (this "Agreement") govern your access to and use of any public repository reports of OTC interest rate derivatives (each a "Report") produced by TriOptima AB ("TriOptima"), as described on the information web page regarding the repository. You must accept this Agreement to access and use Reports. You accept the Agreement by clicking the "I Agree" button on the bottom of this page. TriOptima may at any time, without advance or specific notice, amend this Agreement. Hence, you are expected to review and accept this Agreement each time you wish to access any Report through this website.

2. Intellectual property rights, license to use
    You acknowledge that TriOptima is the sole and exclusive owner of any and all intellectual property rights to the structure and layout of any Report.

    TriOptima hereby grants to you a non-exclusive license to use Reports in accordance with this Agreement.

3. Prohibited use of Reports
    You must not use any Report or the information contained in any Report in a manner that may harm or be detrimental to TriOptima, including without limitation, to use any Report to directly or indirectly compete or promote competition with TriOptima.

    You are not allowed to use TriOptima's name or any trademarks, trade names or service marks contained in any Report or this website in advertising, publicity or otherwise; neither are you allowed to copy any marks, specific characteristics or attributes of any Report for any other purpose than for making a lawful and contractually permitted copy of a Report.

4. Non-reliance, no warranty, disclaimer
    Each Report is provided to you free of charge. However, TriOptima does not warrant or undertake to make any Reports available to you; hence you acknowledge that TriOptima, in its sole discretion, may or may not make Reports available to you via this website or otherwise.

    Each Report is intended for information purposes only. Any information in a Report may at any time be superseded or replaced by new or updated information. Furthermore, the information contained in a Report is based on the information submitted by third parties for the purpose of inclusion in such Report. The information contained in a Report is neither checked, nor verified by TriOptima. Consequently, you acknowledge that Reports are for information purposes only, that they may not be relied upon for any purpose whatsoever, and that they are dependent upon, as regards their accuracy and completeness, the data submitted to TriOptima by third parties.

    The parties acknowledge that TriOptima makes no representation or warranty with respect to any Report or this website or any data or materials retrieved, obtained, provided or transmitted, by or to you, using this website. Each Report and this website and all such data and materials are being provided to you "as is". TriOptima hereby disclaims any and all representations and warranties, whether express or implied, including without limitation, any representation or warranty as to merchantability or fitness for a particular purpose, any representations or warranties arising from course of dealing or course of performance, and any representations or warranties of accuracy, reliability or functionality.

    To the maximum extent permitted by law, TriOptima disclaims all liability arising out of or in connection with the use of any Report or this website.

    Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.

    Notwithstanding anything to the contrary in this Agreement, TriOptima does not exclude or limit its liability for wilful misconduct, fraud or death or personal injury arising from TriOptima's negligence.

    For purposes of this clause, references to TriOptima shall be deemed to include its affiliates and their respective partners, officers, employees, directors, agents, contractors, representatives, successors and assigns.

5. Viruses, malware
    To the best of TriOptima's knowledge, Reports published on this website, this website and the server on which it resides are free from viruses and other malware. However, TriOptima cannot warrant this to be the case, and it is your responsibility to take precautions to prevent your computer and/or network to be affected by viruses or other malware. Hence, TriOptima does not assume any liability for any damage or loss, whether direct or indirect, including loss of data, caused to you by viruses or other malware from Reports published on this website, this website or the server on which it resides, including when you download any Report.

6. Applicable law, disputes
    This Agreement and any non-contractual obligations arising in connection with it shall be governed by English law, without regard to its principles of conflicting laws. Each party submits to the exclusive jurisdiction of the English courts for all purposes relating to this Agreement (including the enforcement of any determinations).
I agree    I decline